These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28253932)

  • 1. Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov.
    Hee SW; Willis A; Tudur Smith C; Day S; Miller F; Madan J; Posch M; Zohar S; Stallard N
    Orphanet J Rare Dis; 2017 Mar; 12(1):44. PubMed ID: 28253932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of interventional clinical trials in rare versus non-rare diseases: an analysis of ClinicalTrials.gov.
    Bell SA; Tudur Smith C
    Orphanet J Rare Dis; 2014 Nov; 9():170. PubMed ID: 25427578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
    Gresham G; Meinert JL; Gresham AG; Meinert CL
    JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen.
    Giannuzzi V; Conte R; Landi A; Ottomano SA; Bonifazi D; Baiardi P; Bonifazi F; Ceci A
    Orphanet J Rare Dis; 2017 Apr; 12(1):64. PubMed ID: 28372595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review and comparison of clinical evidence submitted to support European Medicines Agency market authorization of orphan-designated oncological treatments.
    Winstone J; Chadda S; Ralston S; Sajosi P
    Orphanet J Rare Dis; 2015 Oct; 10():139. PubMed ID: 26511061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of Clinical Trials for Drug Development in Rare Diseases.
    Sakate R; Fukagawa A; Takagaki Y; Okura H; Matsuyama A
    Curr Clin Pharmacol; 2018; 13(3):199-208. PubMed ID: 29866013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000-2020.
    Gresham G; Meinert JL; Gresham AG; Piantadosi S; Meinert CL
    Trials; 2022 Oct; 23(1):858. PubMed ID: 36203212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and Public Availability of Results of Clinical Trials on Rare Diseases Registered at Clinicaltrials.gov.
    Dechartres A; Riveros C; Harroch M; Faber T; Ravaud P
    JAMA Intern Med; 2016 Apr; 176(4):556-8. PubMed ID: 26954340
    [No Abstract]   [Full Text] [Related]  

  • 10. Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.
    Rees CA; Pica N; Monuteaux MC; Bourgeois FT
    PLoS Med; 2019 Nov; 16(11):e1002966. PubMed ID: 31751330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small class sizes for improving student achievement in primary and secondary schools: a systematic review.
    Filges T; Sonne-Schmidt CS; Nielsen BCV
    Campbell Syst Rev; 2018; 14(1):1-107. PubMed ID: 37131395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to sample size calculation for clinical trials in rare diseases.
    Miller F; Zohar S; Stallard N; Madan J; Posch M; Hee SW; Pearce M; Vågerö M; Day S
    Pharm Stat; 2018 May; 17(3):214-230. PubMed ID: 29322632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty.
    Tasneem A; Aberle L; Ananth H; Chakraborty S; Chiswell K; McCourt BJ; Pietrobon R
    PLoS One; 2012; 7(3):e33677. PubMed ID: 22438982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug development for exceptionally rare metabolic diseases: challenging but not impossible.
    Putzeist M; Mantel-Teeuwisse AK; Wied CC; Hoes AW; Leufkens HG; de Vrueh RL
    Orphanet J Rare Dis; 2013 Nov; 8():179. PubMed ID: 24237580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing's sarcoma.
    Dutton P; Love SB; Billingham L; Hassan AB
    Stat Methods Med Res; 2018 May; 27(5):1451-1463. PubMed ID: 27587590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
    Ohnmeiss DD
    Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Orphanet and its consortium: where to find expert-validated information on rare diseases].
    Maiella S; Rath A; Angin C; Mousson F; Kremp O
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S3-8. PubMed ID: 23452769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.
    Nguengang Wakap S; Lambert DM; Olry A; Rodwell C; Gueydan C; Lanneau V; Murphy D; Le Cam Y; Rath A
    Eur J Hum Genet; 2020 Feb; 28(2):165-173. PubMed ID: 31527858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accounting for the rarity of the disease when designing clinical trials with a focus on pediatric cancers.
    Mauguen A
    Clin Trials; 2022 Jun; 19(3):292-296. PubMed ID: 35232288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.